Feasibility of minimally invasive deep brain stimulation via an endovascular stent-electrode.

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Neurocognitive decline in Parkinson's disease refers to the non-motor symptoms of the disease; these symptoms have increasingly become recognised as both prevalent, and evolving early in the disease course. While motor symptoms are treated with drugs and electrodes, the changes to patients� cognition, the progressive dementia, the psychosis and other symptoms progress with poor treatment. This research is designed to identify and understand targets so better treatments can be created.

Funded Activity Details

Start Date: 01-01-2014

End Date: 01-01-2017

Funding Scheme: NHMRC Postgraduate Scholarships

Funding Amount: $122,032.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Central Nervous System

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Parkinson disease | cognition | dementia | dementia with Lewy bodies | dopamine | metals | neurodegeneration | psychosis | synuclein